BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.760
-0.030 (-1.68%)
At close: Jun 18, 2026, 4:00 PM EDT
1.750
-0.010 (-0.55%)
After-hours: Jun 18, 2026, 7:02 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $13.27 million as of June 18, 2026. Its market cap has decreased by -34.29% in one year.
Market Cap
13.27M
Enterprise Value
772.05K
1-Year Change
-34.29%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $13.27M, a decrease of -74.47%. That is a compound annual growth rate of -21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 13.27M | 52.57% |
| Dec 31, 2025 | 8.70M | -75.49% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
| Sep 18, 2020 | 52.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 13.83M |
| IN8bio | 13.59M |
| CalciMedica | 13.51M |
| Cyclerion Therapeutics | 13.49M |
| BioLineRx | 13.48M |
| CytoMed Therapeutics | 13.13M |
| OSR Holdings | 13.11M |
| Cocrystal Pharma | 13.05M |